Target intelligence / Profile preview

Endosialin (None)

Target
None
Molecular classification
Transmembrane glycoprotein, C-type lectin receptor
01

Overview

Endosialin, also known as Tumor Endothelial Marker 1 (TEM1) or CD248, is a transmembrane glycoprotein highly expressed in the tumor stroma, particularly in cancer-associated fibroblasts and pericytes. It plays a role in promoting tumor progression through enhancing cell adhesion, migration, and proliferation, stimulating angiogenesis, and inducing an immunosuppressive microenvironment. Due to its restricted expression outside tumors, it is considered an attractive target for anti-cancer therapy.

Other names
Tumor Endothelial Marker 1TEM1CD248CD164L1
02

Mechanism of action

Antibody-mediated internalization and disruption of vessel function

03

Biological functions

Cell adhesionCell migrationCell proliferationAngiogenesisImmunomodulationExtracellular matrix interaction
04

Disease associations

CancerAtherosclerosis
05

Interacting drugs

MORAb‑004

Beyond the preview

Go deeper on Endosialin (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endosialin (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call